Revision summary
Nanotechnology designs matter at 1–100 nanometres, where surfaces and optics change. Health uses include targeted drug carriers, imaging agents, and antimicrobial coatings. Lateral-flow tests and liposomal chemotherapies are working examples. Lipid nanoparticles enabled mRNA COVID vaccines in 2020. Toxicity, cost, and hype require regulation, not blanket enthusiasm.
Model answer
Copper italics in this answer — like this — are the key facts. Each one is unpacked in the Facts & figures rail.
Introduction
Nanotechnology is the design and use of materials and devices at the scale of roughly 1–100 nanometres, where surface chemistry and quantum behaviour differ from bulk matter. In health it is a set of tools for seeing, delivering, and killing at the scale of cells and proteins — not a single drug and not a magic powder.
Body
What it is
- A nanometre is one-billionth of a metre. At that size, gold, carbon, lipids, and polymers can be shaped as particles, tubes, shells, and films with new optical, catalytic, or barrier properties.
- It sits across physics, chemistry, biology, and engineering: nanomedicine is the health slice.
- India funds it through Nano Mission (DST) and related DBT/ICMR work, with the usual need for toxicity and ethics review.
Help in the health sector
- Drug delivery: liposomes and polymeric nanoparticles carry chemo or amphotericin to a target tissue, which can cut systemic toxicity (Doxil-type liposomal doxorubicin is the classic class).
- Diagnostics and imaging: gold nanoparticles and quantum dots improve assays and contrast; lateral-flow tests use gold conjugates — the same family as many rapid antigen strips.
- Antimicrobials: silver nanoparticles in coatings and some dressings; nano-enabled surfaces in hospitals. Stewardship still matters; nano is not a licence to skip hygiene.
- Vaccines and biologics: lipid nanoparticles became the delivery chassis for mRNA COVID vaccines in 2020 — a global health use of nano-formulation, even if India’s first COVID shots were other platforms.
- Implants and tissue: nano-textured surfaces for better osseointegration; scaffolds for regenerative work still largely in trial.
- Theranostics: particles that both image and treat, especially in oncology research.
Cautions
- ADME and toxicity of persistent nanoparticles are not fully known; regulation must treat them as new entities, not as tiny versions of bulk powder.
- Cost and cold-chain for advanced nano-drugs can exclude public-hospital patients unless procurement is deliberate.
- Hype in cosmetics and ‘nano-Ayurveda’ claims should not be confused with peer-reviewed nanomedicine.
Flow diagram
Conclusion
Nanotechnology is engineering at the billionth-of-a-metre scale. In health it already helps targeted drugs, rapid tests, coatings, and — globally in 2020 — lipid-nanoparticle vaccines. It helps as regulated medicine, not as a slogan on a bottle.
Quick related
Students also ask
-
Explain the meaning of investment in an economy in terms of capital formation. Discuss the factors to be considered while designing a concession agreement between a public entity and a private entity.
Next question on this syllabus topic (2020 · Q11). View answer →
-
Is every nanoparticle a medicine?
No. Size is a property. Benefit depends on a tested formulation, dose, and regulator path.
-
Did nanotechnology cure COVID?
It contributed delivery systems and diagnostics. Public health still needed distance, oxygen, and vaccination programmes.
Same topic · past papers
UPSC has asked this before
These previous-year questions sit on the same topic. Open one to practise the earlier ask.
More from this topic
Q17 · UPSC Mains 2026 · GS III · 15 marks · Solution
What are the challenges to solid waste management in India? Discuss the governmental policy framework on solid waste management. Discuss the success/failure cases of Delhi and Indore cities highlighting the salient features of their solid waste management initiatives.
Indian Economy
• Challenges: volume growth, mixed waste, land, informal exclusion, weak finance. • SWM Rules 2016 mandate segregation, collection, processing, user fees. • Plastic/C&D/e-waste rules and SBM Urban complete the framework. • Swachh Survekshan creates competitive accountability. • Indore: strong segregation, collection, processing, enforcement. • Delhi: huge volumes, legacy dumps, fires, fragmented stress. • Lesson: behaviour + processing beat trucks-only strategies. • Biomining and bulk-generator compliance are essential for metros.
Q16 · UPSC Mains 2026 · GS III · 15 marks · Solution
What is Agentic Artificial Intelligence (AI)? Explain its working. Describe its applications with suitable examples. Discuss the advantages, risks and challenges associated with agentic AI systems.
Indian Economy
• Agentic AI pursues goals via plan–act–observe loops, not one-shot replies. • Working parts: planning, tools, memory, guardrails, stop conditions. • Uses: grievance assist, compliance, agri/disaster fusion, cyber SOCs, tutoring. • Advantages: speed, consistency, expert leverage, continuous monitoring. • Risks: harmful actions from hallucinations, injection attacks, privacy leaks. • India challenges: languages, liability, data law, compute cost, evaluation. • Govern with human approval for high stakes, logs and allow-listed tools. • Sandboxes beat unsupervised autonomy over money and rights.
Q15 · UPSC Mains 2026 · GS III · 15 marks · Solution
Mention salient features of 'Mission Drishti'. Discuss the imaging techniques used in the satellite launched on 3rd May 2026. Why is it being considered world's first satellite of its kind?
Indian Economy
• Mission Drishti is GalaxEye's EO satellite launched 3 May 2026. • Marketed as world's first OptoSAR combining optical + all-weather radar. • Described as India's largest privately built satellite in that category. • Imaging: X-band SAR (Stripmap/Spotlight) plus 7-band MSI. • Fusion on one platform avoids two-satellite parallax/time errors. • Fused resolution marketed near 1.8 m; SAR spotlight finer (~0.9 m claimed). • Orbit: sun-synchronous LEO ~500 km class; revisit ~4 days (company). • Novelty is integrated commercial OptoSAR—not inventing SAR/optical physics.